Assistance Publique Hôpitaux de Paris - CHU Henri Mondor
Créteil, Val-de-marne, 94010, France
Location status: Recruiting
Location contact
Claire HOTZ, MD-PhD
CONTACT
Philippe Le Corvoisier, MD-pHD
CONTACT
NCT Number: NCT05531747
Hidradenitis Suppurativa is a recurrent chronic inflammatory follicular occlusive disease affecting hair follicles. HS is notoriously difficult and challenging to treat with a high morbidity impact and could be classified as an unmet medical need with no efficient therapeutic options.
Objective:
Investigators previously showed that Outer Root Sheath Cells (ORS) isolated from hair follicle of HS patients (HS-ORS) have a pro-inflammatory phenotype and secrete spontaneously IP-10 and RANTES. To identify the mechanisms involved in the pro-inflammatory phenotype of HS-ORS, investigators performed a transcriptomic analysis in healthy and HS patients. This revealed: (i) an IFN signature, (i) a dysregulation of genes involved in cell proliferation and differentiation, and (iii) an upregulation of DNA damage response and cell cycle G2/M checkpoint pathways in HS-ORS. These findings support the notion that, in HS patients, a perturbation of HF-SC homeostasis leading to an increased proliferation induces a replicative stress and an accumulation of cytoplasmic ssDNA, stimulating IFN synthesis through IFI16-STING pathway. Interestingly, replicative stress in ORS were present in some but not all patients with Hidradenitis Suppurativa. The goal of study is to determine replicative stress in ORS in a large cohort of HS patients.
Method Patients will be enrolled in the Mondor Dermatology department, during routine care. A dermatologist will check all inclusion and exclusion criteria with the technical support of a research technician of the Henri Mondor Clinical Investigation Center. Medical history, clinical data, comorbidities and concomitant therapies will be prospectively recorded in a dedicated case report form. Skin biopsies will be performed in perilesional zone rich in hair follicles. mRNA will be extracted from freshly isolated hair follicle cells and some slides will be prepared and stored at -80°C to perform immunohistochemistry analysis on freshly isolated hair follicle cells. PBMC and serum will be collected.
All these biological samples will allow us to quantify the replicative stress in HS-ORS of each patient, and to quantify several cytokine of interest : IFN de type 1, IL-17, IL-6, TNF-α, IL-10
This study will allow investigators to evaluate the rate of patients with replicative stress in hair follicle stem cells in Hidradenitis Suppurativa. The investigator will also determine whether HF-SC replication stress correlates with clinical characteristics and/or with clinical course and/or comorbidities.
Interested in participating?
Request Info18 year–99 year
All sexes
Interventional
Not applicable
Créteil, Val-de-marne, 94010, France
Location status: Recruiting
Claire HOTZ, MD-PhD
CONTACT
Philippe Le Corvoisier, MD-pHD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A maximum of 2 superficial skin biopsies (epidermis/dermis), allowing 10 hair follicles to be obtained, at the edge of the affected area, in healthy territory (excluding the face and folds but not excluding the pubic region), at initiation visit.
42mL of blood (6 tubes of 7mL) sampled at initiation visit
Time frame: The primary outcome will be evaluated at baseline
Evaluation of the rate of patients with replicative stress in hair follicle stem cells in Hidradenitis Suppurativa
Contact information is provided by the study sponsor or research team.
Claire HOTZ, MD
CONTACT
Philippe Le Corvoisier, MD PhD
CONTACT
Assistance Publique - Hôpitaux de Paris
Other
Acronym: Fol-Hydra
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04246372
Abnormalities, Multiple, Alopecia
Aurora, Colorado, United States
View Trial DetailsNCT03668925
Arthritis, Bacterial Infections
Reims, France
View Trial DetailsNCT05889182
Bacterial Infections, Bacterial Infections and Mycoses
Birmingham, Alabama, United States
View Trial DetailsNCT07049575
Bacterial Infections, Bacterial Infections and Mycoses
Phoenix, Arizona, United States
View Trial Details